Literature DB >> 16720896

Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Sebastian George Barton Furness1, Kelly McNagny.   

Abstract

CD34, podocalyxin, and endoglycan are members of a family of single-pass transmembrane proteins that show distinct expression on early hematopoietic precursors and vascular-associated tissue. In spite of the fact that the expression of CD34 on these early progenitors has been known for over 20 yr and used clinically in hematopoietic stem cell transplantation for more than 15 yr, little is known about its exact role or function. More recently, CD34 expression has been shown to distinguish activated early progenitors from quiescent cells. With the subsequent identification of podocalyxin and endoglycan as related family members also expressed on early progenitor cells, attention is slowly shifting toward understanding how these molecules might contribute to progenitor function and behavior. In this review we examine the existing evidence and propose testable models to reveal the importance of these molecules for stem and progenitor cell function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720896     DOI: 10.1385/IR:34:1:13

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  115 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

3.  Cell surface membrane antigen phenotype of human gastrointestinal mast cells.

Authors:  Maria-Theresa Krauth; Yasamin Majlesi; Stefan Florian; Alexandra Bohm; Alexander W Hauswirth; Minoo Ghannadan; Friedrich Wimazal; Markus Raderer; Friedrich Wrba; Peter Valent
Journal:  Int Arch Allergy Immunol       Date:  2005-09-20       Impact factor: 2.749

4.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

Authors:  M A Goodell; M Rosenzweig; H Kim; D F Marks; M DeMaria; G Paradis; S A Grupp; C A Sieff; R C Mulligan; R P Johnson
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

5.  Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells.

Authors:  P Welker; J Grabbe; T Zuberbier; S Guhl; B M Henz
Journal:  J Invest Dermatol       Date:  2000-01       Impact factor: 8.551

6.  Immunocytochemical characterization of lymphocyte development in human embryonic and fetal livers.

Authors:  J Abe
Journal:  Clin Immunol Immunopathol       Date:  1989-04

7.  Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

8.  Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium.

Authors:  M W Seiler; H G Rennke; M A Venkatachalam; R S Cotran
Journal:  Lab Invest       Date:  1977-01       Impact factor: 5.662

9.  Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin.

Authors:  A Bistrup; S Bhakta; J K Lee; Y Y Belov; M D Gunn; F R Zuo; C C Huang; R Kannagi; S D Rosen; S Hemmerich
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

10.  Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors.

Authors:  K M McNagny; I Pettersson; F Rossi; I Flamme; A Shevchenko; M Mann; T Graf
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

View more
  41 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

2.  Current and future status of stem cell therapy in heart failure.

Authors:  David A D'Alessandro; Robert E Michler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-12

Review 3.  Adhesion receptors involved in HSC and early-B cell interactions with bone marrow microenvironment.

Authors:  Maria De Grandis; Anne-Catherine Lhoumeau; Stéphane J C Mancini; Michel Aurrand-Lions
Journal:  Cell Mol Life Sci       Date:  2016-02       Impact factor: 9.261

4.  Novel roles for podocalyxin in regulating stress myelopoiesis, Rap1a, and neutrophil migration.

Authors:  Pan Li; Aldona A Karaczyn; Rose McGlauflin; Amanda J Favreau-Lessard; Edward Jachimowicz; Calvin P Vary; Kailin Xu; Don M Wojchowski; Pradeep Sathyanarayana
Journal:  Exp Hematol       Date:  2017-04-10       Impact factor: 3.084

5.  Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo.

Authors:  Jacqueline E Testa; Adrian Chrastina; Phil Oh; Yan Li; Halina Witkiewicz; Malgorzata Czarny; Tim Buss; Jan E Schnitzer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464

Review 6.  Stem cell therapy for heart failure.

Authors:  Robert E Michler
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec

7.  Regulation of cell shape and adhesion by CD34.

Authors:  Hiroe Ohnishi; Hiroyuki Sasaki; Yoshihiko Nakamura; Shunichi Kato; Kiyoshi Ando; Hisashi Narimatsu; Kouichi Tachibana
Journal:  Cell Adh Migr       Date:  2013-08-05       Impact factor: 3.405

Review 8.  Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders.

Authors:  Ryan P Berger; Michelle Dookwah; Richard Steet; Stephen Dalton
Journal:  Bioessays       Date:  2016-09-26       Impact factor: 4.345

9.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

10.  Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat.

Authors:  Jacqueline E Testa; Adrian Chrastina; Yan Li; Phil Oh; Jan E Schnitzer
Journal:  J Vasc Res       Date:  2009-01-10       Impact factor: 1.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.